ZYZhiwei Yang

Zhiwei Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhiwei Yang has a total of 180 co-authors. Here are the top co-authors by number of shared publications:

  • Xing Liu

    Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), National Center of Technology Innovation for Animal Model, NHC Key Laboratory of Human Disease Comparative Medicine, National Human Diseases Animal Model Resource Center, Beijing, 100021, China

    21 shared publications
  • Xiaoliang Jiang

    NHC Key Laboratory of Human Disease Comparative Medicine, Institute of Laboratory Animal Sciences (CAMS & PUMC) National Center of Technology Innovation for Animal Model, National Human Diseases Animal Model Resource Center, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Beijing P.R. China

    15 shared publications
  • Xianxian Wu

    Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Centre, Peking Union Medical College (PUMC), Beijing 100021, China

    11 shared publications
  • Xue Liu

    Institute of Laboratory Animal Sciences (CAMS & PUMC) National Center of Technology Innovation for Animal Model National Human Diseases Animal Model Resource Center NHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases 100021 Beijing China

    7 shared publications
  • Pedro A. Jose

    Department of Pharmacology and Physiology (P.A.J.), The George Washington University School of Medicine and Health Sciences, Washington, DC

    6 shared publications
  • Yuhan Li

    Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Centre, Peking Union Medical College (PUMC), Beijing 100021, China

    5 shared publications

Latest Publications

  • Open Access

    Sex Disparities in Recorded Heart Failure-Attributed Mortality Among Adults Aged 20–49 Years: A 25-Country Comparison with Broader Mortality Categories

    by Guoqing Li, Yuhan Zhang, Ye Wang, Xiaoliang Jiang, Rongyan Jiang, Zhiwei Yang

    Whether the relative male excess in recorded heart failure (HF)-attributed mortality among adults aged 20–49 years is greater than that for broader mortality categories is unclear. We analysed World Health Organization underlying cause death data for adults aged 20–49 years in 25 countries with complete data for 2001–2019. Stacked count models compared male-to-female mortality rate ratios (MRRs) for HF-attributed, other circulatory, and non-HF all-cause mortality; secondary models estimated temporal changes. Among 200,707 HF-attributed deaths, the median ratio of MRRs was 0.895 for HF-attributed versus other circulatory mortality and 1.128 versus non-HF all-cause mortality. Confidence intervals were entirely above 1 in 4 and 6 of 25 countries, respectively, and entirely below 1 in 5 and 1. Results were similar when the contrast was allowed to vary over time and when the United States, Canada, and Mexico were added, but the comparison with non-HF all-cause mortality depended on the age range. As secondary findings, mortality declined in both sexes in 10 countries, and a male disadvantage was present in 18 countries in both 2001 and 2019. Across these 25 countries, the relative male excess in recorded HF-attributed mortality was not consistently greater than that for broader mortality categories.

  • Open Access

    Kcna3 Deficiency Promotes Renin-Associated Hypertension Through Ca2+-Dependent AKT–PKA–CREB Signaling

    by Ye Wang, Shiyun Sun, Yuhan Zhang, Guoqing Li, Yunlong Xu, Yingxue Shi, Pedro A. Jose, Zhiwei Yang, Xing Liu, Xiaoliang Jiang

    Hypertension is an important risk factor for cardiovascular and renal diseases, yet the mechanisms linking ion channel dysfunction to hypertension remain poorly understood. The voltage-gated potassium channel Kv1.3 (encoded by Kcna3) regulates membrane potential, but its role in the pathogenesis of hypertension remains unclear. In this study, we employed Kcna3 knockout (KO) mice, transcriptomic profiling, and pharmacological inhibition to investigate the role of Kv1.3. Kcna3-deficient mice showed increased blood pressure and renal fibrosis. Transcriptomic profiling showed activation of the renin–angiotensin–aldosterone system (RAAS), with increased renin expression in both Kcna3-deficient mice and Kv1.3 inhibitor-treated cells. Mechanistically, loss of Kv1.3 increased intracellular Ca2+ accumulation, activating the phosphoinositide 3-kinase (PI3K)-AKT and protein kinase A (PKA) pathways, leading to cAMP response element binding protein (CREB) phosphorylation and renin upregulation. Pharmacological inhibition of Ca2+ signaling or PKA reduced CREB phosphorylation and renin expression, confirming a causal signaling cascade. Thus, Kv1.3 links membrane excitability to RAAS activation via a Ca2+-dependent AKT–PKA–CREB signaling axis and represents a potential therapeutic target for hypertension and associated renal injury.

  • G6PD inhibition prevents abdominal aortic aneurysm formation in mice induced by Ang II plus high salt

    by Zhihui Wang, Yang Shi, Dou Shi, Hongyu Deng, Jinyang Zhang, Yuhan Zhang, Xing Liu, Xianxian Wu, Zhiwei Yang

  • Open Access

    Knockout of α-Synuclein Is Associated with Depression-like Behaviors by Altered Excitability of Medial Prefrontal Cortex Neurons in Mice

    by Tong Shang, Yu Zhang, Xueling Zhang, Wei Liang, Yunlin Han, Zhiwei Yang, Ling Zhang, Chuan Qin

    To investigate the neural circuit mechanisms linking the physiological loss of α-synuclein (α-syn) function to depressive-like states, we explored whether constitutive α-syn depletion disrupts the excitation and inhibition balance within the medial prefrontal cortex. We integrated comprehensive behavioral paradigms, whole-cell patch-clamp electrophysiology, and targeted chemogenetics within an α-syn knockout mouse model. Behavioral profiling revealed that α-syn deficiency was accompanied by basal psychomotor hyperactivity and profound stress-coping deficits. Cellular electrophysiology in the medial prefrontal cortex demonstrated a significantly enhanced intrinsic excitability across both GABAergic and glutamatergic populations. Furthermore, targeted chemogenetic suppression of GAD67-positive interneurons partially alleviated the depressive-like phenotype without confounding baseline locomotion. In summary, the physiological depletion of endogenous α-syn is associated with altered stress-coping behaviors and increased mPFC neuronal excitability. Chemogenetic suppression of mPFC GAD67-positive interneurons partially reduces immobility in SYN-KO mice, implicating prefrontal inhibitory circuit dysregulation in these behavioral alterations. These findings underscore the importance of α-syn homeostasis in modulating cortical microcircuits and provide novel insights into the early non-motor manifestations of synucleinopathies.

  • Human obese gut microbiota induces lipid metabolic disorder and hypophagia without weight gain in normocaloric mice

    by Yang Shi, Xing Liu, Yun Yang, Hongyu Deng, Jinyang Zhang, Dou Shi, Yuhan Zhang, Yuanzhi Cheng, Yaxi Guo, Hua Zhu, et al.


  • Open Access

    Animal models of hypertension and concurrent organs injury

    by Ye Wang, Xiaoliang Jiang, Zhiwei Yang

    Although hypertension is a frequently seen chronic condition across the world, its exact cause remains unclear. Animal models are beneficial for clarifying the pathogenic mechanism of hypertension and examining new treatments. An optimal animal model for studies on hypertension must well mimic human‐like hemodynamics and pathophysiological structural modification, showing human disease features and complications timely or even ahead of time. A review of the most frequently used hypertensive animal models available, including small and large animals, induced and genetic models, would provide an insight into the appropriate targets to be addressed in the development of different hypertensive animal models. Another focus of the review are the processes of target‐organs injury caused by high blood pressure, which mainly influences human health.

  • Open Access

    Single-cell RNA sequencing reveals endothelial cell heterogeneity and Sox18-mediated EndMT in abdominal aortic aneurysm

    by Xianxian Wu, Xuanyu Liu, Yuanzhi Cheng, Yuhan Zhang, Dou Shi, Yang Shi, Xing Liu, Jianghao Feng, Anxiong Long, Wei Hu, et al.

    Rationale: Abdominal aortic aneurysm (AAA) is a life-threatening cardiovascular disease lacking clinical predictors and effective pharmacologic therapies. The cellular heterogeneity and molecular changes of different cell types during AAA have been revealed in human and mouse aortas by single-cell RNA sequencing (scRNA-seq) technology. However, the heterogeneity and plasticity of endothelial cells (ECs) in AAA remain poorly characterized.


  • Top Cited Papers
    Open Access

    The Pathophysiological Role of Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysm

    by Dou Shi, Mo Zhang, Yuhan Zhang, Yang Shi, Xing Liu, Xianxian Wu, Zhiwei Yang

    Abdominal aortic aneurysm (AAA) is the most common aortic disease occurring below the renal arteries, caused by multiple etiologies. Currently, no effective drug treatment exists, and the specific pathogenesis remains unclear. Due to its insidious onset and diagnostic challenges, AAA often culminates in aortic rupture, which has a high mortality rate. During AAA development, vascular smooth muscle cells (VSMCs) undergo significant pathological alterations, including contractile dysfunction, phenotypic modulation, cellular degradation, and heightened inflammatory and oxidative stress responses. In particular, emerging evidence implicates vascular smooth muscle cell (VSMC) metabolic dysregulation and mitochondrial dysfunction as key contributors to AAA progression. In this review, we systematically summarize the current understanding of VSMC biology, including their developmental origins, structural characteristics, and functional roles in aortic wall homeostasis, along with the regulatory networks governing the VSMC phenotype and functional maintenance. This review highlights the urgent need for further investigation into the aortic wall VSMC pathophysiology to identify novel therapeutic targets for AAA. These insights may pave the way for innovative treatment strategies in aortic disease management.


  • A novel transgenic miniature pig model of human PSGL-1 reveals critical roles in thrombosis, inflammation, and immune perturbation

    by Anxiong Long, Xing Liu, Shiyun Sun, Xianxian Wu, Xiaoliang Jiang, Wei Liu, Jianghao Feng, Xiao Chen, Yuanzhi Chen, Yuhan Zhang, et al.


  • Open Access

    Foxk1 and Foxk2 promote cardiomyocyte proliferation and heart regeneration

    by Dongcheng Cai, Chungeng Liu, Haotong Li, Chiyin Wang, Lina Bai, Jie Feng, Miaoqing Hu, Hao Wang, Shen Song, Yifan Xie, et al.

    Promoting endogenous cardiomyocyte proliferation is a promising strategy for cardiac repair. Identifying key factors that regulate cardiomyocyte proliferation can advance the development of novel therapies for heart regeneration. Here, we identify Foxk1 and Foxk2 as key regulators of cardiomyocyte proliferation, whose expression declines during postnatal heart development. Cardiomyocyte-specific knockout of Foxk1 or Foxk2 impairs neonatal heart regeneration after myocardial infarction (MI) injury. AAV9-mediated Foxk1 or Foxk2 overexpression extends the postnatal cardiomyocyte proliferative window and enhances cardiac repair in adult mice after MI. Mechanistically, Foxk1 and Foxk2 drive cardiomyocyte cell cycle progression by directly activating CCNB1 and CDK1 expression, forming the CCNB1/CDK1 complex that facilitates G2/M transition. Moreover, Foxk1 and Foxk2 promote cardiomyocyte proliferation by upregulating HIF1α expression, which enhances glycolysis and the pentose phosphate pathway (PPP), which further favors cardiomyocyte proliferation. These findings establish Foxk1 and Foxk2 as promising therapeutic targets for cardiac injury.